Matinas BioPharma announced a strategic collaboration with National Resilience, Inc. (Resilience). The parties have entered into a Material Transfer and Evaluation Agreement focused on exploring the potential for oral delivery of identified nucleic acids. The parties will closely collaborate on a comprehensive research program comprising the design, formulation, optimization, and in vitro and in vivo testing of these nucleic acid formats in combination with Matinas' proprietary LNC platform.

Terms of the collaboration were not otherwise disclosed.